| Literature DB >> 35746022 |
Zohaib Khurshid1, Binoy Mathews Nedumgottil1, Ramy Moustafa Moustafa Ali1,2, Sompop Bencharit3, Shariq Najeeb4.
Abstract
INTRODUCTION: Polyetheretherketone (PEEK) is a polymer that is used in the construction of orthopaedic and dental implants. It is also used to construct removable and fixed dental prostheses due to its superior mechanical and esthetic properties compared to conventional materials. This systematic review aims to analyse and appraise the literature concerning PEEK dental prostheses critically.Entities:
Keywords: dental implants; dental prostheses; obturators; polyetheretherketone; prosthodontics
Year: 2022 PMID: 35746022 PMCID: PMC9231096 DOI: 10.3390/polym14122441
Source DB: PubMed Journal: Polymers (Basel) ISSN: 2073-4360 Impact factor: 4.967
Figure 1PRISMA flow diagram of the search methodology employed for this review.
A list of the full texts excluded along with reasons for exclusion.
| Study | Reason for Exclusion |
|---|---|
|
| Only workflow; PEEK denture not delivered to patient |
|
| PEEK framework not used |
|
| PEEK framework not used |
General characteristics of studies included in this review. PEEK: polyetheretherketone; N/A: not application; CAD: computer-aided design; CAM: computer-aided manufacture.
| No. | Study—Author(s) and Year | Type of Study | Patient (s) (n) | Age (Mean/Range) | Type/Brand of PEEK | Rehabilitation Details and/or Study Groups | Fabrication | Implants Placed (n) | Implant Dimensions (mm) | Duration of Study |
|---|---|---|---|---|---|---|---|---|---|---|
|
| Costa-Palau et al., 2014 | Case report | 1 | 58 years | PEEK-Optima | Maxillary obturator. | Mechanical duplication of old obturator. | 0 | N/A | 6 months |
|
| Zoidis and Papathanasiou, 2016 | Case report | 1 | 52 years | BioHPP PEEK | Interim fixed implant-supported 3-unit prosthesis. | Digital scanning of wax pattern and injection molding. | 2 | L = 11.5 | 4 months |
|
| Hahnel et al., 2017 | Case report | 1 | 76 years | Ceramill PEEK | Interim maxillary all-on-four implant-supported PEEK fixed prosthesis. | Conventional wax pattern. | 4 | NR | 3 months |
|
| Zoidis 2017 | Case report | 1 | 65 years | BioHPP PEEK | Definitive maxillary fixed all-on-four implant-supported PEEK framework and PMMA base and veneers. | Conventional impression. Lost-wax and casting. | 4 | L = 11.5 | 2 years |
|
| Sinha et al., 2017 | Case report | 1 | 32 years | PEEK-Optima | FPD. Upper and lower incisors replaced with canine–canine abutments. PEEK framework with resin composite veneers. | Conventional impression. Lost-wax and casting. | 0 | N/A | 6 months |
|
| Zoidis 2018 | Case report | 1 | 85 years | BioHPP PEEK | Removable mandibular PEEK framework and PMMA base retained by high noble ball attachments on both canines. | Conventional impression. | 0 | N/A | Not reported |
|
| Harb et al., 2018 | Case report | 1 | 56 years | CeraMill PEEK | Removable PEEK mandibular Kennedy class I framework and PMMA base to replace first and second molars. | Conventional impressions. | 0 | N/A | Not reported |
|
| Mangano et al., 2019 | Prospective cohort | 15 | 68.8 ± 4.7 years | Not recorded | Each patient received one removable maxillary overdenture supported by 4 implants and PEEK bar. | CAD–CAM replication of a relined denture. | 60 | L = 8–14 | 1 year |
|
| Tasopoulos et al., 2020 | Case report | 1 | 47 years | BioHPP | Two-piece PEEK maxillary obturator; Kennedy Class II (canine to second molar). Acrylic supported by PEEK framework. | Material: BioHPP | 0 | N/A | 1 year |
|
| Wang et al., 2021 | Retrospective cohort | 43 | 59.8 years | BioHPP | Full-mouth FDP, 6 implants per arch (n = 60): | CAD: D2000 3D Scanner, 3Shape | 331 | N/A | 5 years |
|
| Sharaf and Eskandar 2021 | Randomised control trial | 18 | Not stated | Dental Direkt | Group I: Attachment-retained obturator with PEEK framework (n = 6) | Conventional impressions. | 0 | N/A | 12 months |
|
| Russo et al., 2021 | Case-control | 16 | 46–72 years | Not specified | Group I: RPD (n = 10) | CAD: TRIOS 3, 3Shape | 0 | N/A | 1 year |
Implant and prosthodontic outcomes of studies included in this review. PEEK: polyetheretherketone; BOP: bleeding on probing; TMJ: temporomandibular joint; VBL: vertical bone loss.
| No. | Study—Author(s) and Year | Implant Outcomes | Prosthodontic Outcomes |
|---|---|---|---|
|
| Costa-Palau et al., 2014 | No implants placed | No complications reported |
|
| Zoidis and Papathanasiou, 2016 | No complications reported | No complications reported |
|
| Hahnel et al., 2017 | No complications reported | No complications reported. OVD increased successfully on final follow-up |
|
| Zoidis 2017 | No complications reported | No complications reported |
|
| Sinha et al., 2017 | No implants placed | No complications reported |
|
| Zoidis 2018 | No implants placed | No complications reported |
|
| Harb et al., 2018 | No implants placed | No complications reported |
|
| Mangano et al., 2019 | Peri-implantitis developed around 2 implants | 20% of the dentures failed due to inadequate passive fit. 2 fractured dentures had to be repaired. |
|
| Tasopoulos et al., 2020 | No implants placed | No complications reported |
|
| Wang et al., 2021 | BOP: PEEK: 13.8%; Ti: 16.1% | 5-year survival rate of PEEK and titanium overdentures comparable (93.1% and 93.5%, respectively). |
|
| Sharaf and Eskandar 2021 | No implants placed | Group I and II exhibited lesser bone loss and greater patient satisfaction than Group III. No statistical difference between Groups I and II. |
|
| Russo et al., 2021 | No implants placed | No significant differences between residual ridge changes in both groups |
Quality assessment results of the case reports included in this review.
|
|
| |||||||
|
| Costa-Palau et al., 2013 | Zoidis and Papathanasiou, 2016 | Hahnel et al., 2017 | Zoidis 2017 | Sinha et al., 2017 | Zoidis 2017 | Harb et al., 2018 | Tasopoulos et al., 2020 |
|
| Yes | Yes | Yes | Yes | No | Yes | Yes | No |
|
| ||||||||
|
| No | No | No | No | Yes | Yes | Yes | No |
|
| ||||||||
|
| No | No | Yes | Yes | Yes | Yes | No | No |
|
| No | No | No | No | No | No | No | No |
|
| No | No | Yes | No | No | No | No | No |
|
| Yes | Yes | Yes | Yes | No | No | No | Yes |
|
| ||||||||
|
| Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
|
| ||||||||
|
| Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
|
| Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
|
| Yes | No | No | Yes | No | No | No | Yes |
|
| Yes | No | Yes | Yes | No | No | Yes | Yes |
|
| ||||||||
|
| Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
|
| ||||||||
|
| No | No | No | No | No | No | No | No |
|
| ||||||||
|
| Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
|
| Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
|
| No | No | No | No | Yes | Yes | No | |
|
| ||||||||
|
| Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
|
| Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
|
| Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
|
| ||||||||
|
| Yes | Yes | Yes | Yes | Yes | No | No | Yes |
|
| Yes | Yes | Yes | Yes | No | No | Yes | No |
|
| Yes | Yes | Yes | Yes | Yes | No | Yes | Yes |
|
| No | Yes | Yes | Yes | Yes | No | No | No |
|
| ||||||||
|
| No | No | No | No | No | No | No | No |
|
| No | Yes | Yes | No | No | Yes | Yes | Yes |
|
| Yes | Yes | Yes | Yes | No | Yes | Yes | Yes |
|
| Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
|
| No | No | No | No | No | No | No | No |
|
| Low | Low | Medium | Medium | Low | Low | Low | Low |
Quality assessment of the observational studies included in this review.
| Section/Topic | Mangano et al., 2019 | Wang et al., 2021 | Russo et al., 2021 |
|---|---|---|---|
|
| |||
|
| No | Yes | No |
|
| Yes | Yes | Yes |
|
| |||
|
| Yes | Yes | Yes |
|
| Yes | Yes | Yes |
|
| |||
|
| Yes | Yes | Yes |
|
| Yes | Yes | Yes |
|
| |||
|
| No | Yes | No |
|
| No | No | No |
|
| |||
|
| Yes | Yes | Yes |
|
| |||
|
| Yes | Yes | Yes |
|
| |||
|
| No | No | No |
|
| |||
|
| No | No | No |
|
| |||
|
| No | No | No |
|
| |||
|
| Yes | Yes | Yes |
|
| No | No | No |
|
| No | No | No |
|
| No | No | No |
|
| No | No | No |
|
| |||
|
| |||
|
| Yes | Yes | Yes |
|
| No | No | No |
|
| No | No | No |
|
| |||
|
| No | No | No |
|
| No | No | No |
|
| Yes | Yes | Yes |
|
| |||
|
| Yes | Yes | Yes |
|
| |||
|
| Yes | Yes | No |
|
| No | No | No |
|
| Yes | No | No |
|
| |||
|
| Yes | Yes | Yes |
|
| Yes | Yes | Yes |
|
| Yes | Yes | Yes |
|
| Yes | Yes | Yes |
|
| Yes | Yes | Yes |
|
| Medium | Medium | Medium |
Quality assessment results of the quality assessment of the randomised controlled trial included in this review.
| Section/Topic | Quality Assessment |
|---|---|
|
|
|
|
| Yes |
|
| Yes |
|
| |
|
| Yes |
|
| Yes |
|
| |
|
| Yes |
|
| No |
|
| Yes |
|
| No |
|
| Yes |
|
| |
|
| No |
|
| Yes |
|
| Yes |
|
| Yes |
|
| Yes |
|
| No |
|
| Yes |
|
| No |
|
| Yes |
|
| |
|
| Yes |
|
| Yes |
|
| Yes |
|
| No |
|
| No |
|
| Yes |
|
| Yes |
|
| No |
|
| No |
|
| No |
|
| |
|
| No |
|
| Yes |
|
| Yes |
|
| |
|
| Yes |
|
| Yes |
|
| Yes |
|
| Medium |